ImmunityBio, Inc. Annual Interest Expense in USD from 2013 to 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
ImmunityBio, Inc. quarterly/annual Interest Expense history and growth rate from 2013 to 2024.
  • ImmunityBio, Inc. Interest Expense for the quarter ending December 31, 2024 was $26.1M, a 18.2% decline year-over-year.
  • ImmunityBio, Inc. Interest Expense for the twelve months ending December 31, 2024 was $115M, a 11.1% decline year-over-year.
  • ImmunityBio, Inc. annual Interest Expense for 2024 was $115M, a 11.1% decline from 2023.
  • ImmunityBio, Inc. annual Interest Expense for 2023 was $129M, a 103% increase from 2022.
  • ImmunityBio, Inc. annual Interest Expense for 2022 was $63.5M, a 328% increase from 2021.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $115M -$14.3M -11.1% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-03
2023 $129M +$65.4M +103% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-03
2022 $63.5M +$48.7M +328% Jan 1, 2022 Dec 31, 2022 10-K 2025-03-03
2021 $14.8M +$5.78M +63.6% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-19
2020 $9.07M +$3.15M +53.3% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-01
2019 $5.92M Jan 1, 2019 Dec 31, 2019 10-K 2022-03-01
2017 $618K +$552K +836% Jan 1, 2017 Dec 31, 2017 10-K 2018-03-12
2016 $66K +$66K Jan 1, 2016 Dec 31, 2016 10-K 2018-03-12
2015 $0 -$471K -100% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-12
2014 $471K +$8K +1.73% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-15
2013 $463K Jan 1, 2013 Dec 31, 2013 10-K 2016-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.